Ikena Oncology, Inc. Gains 1152.55%

Wed, Jul 30, 2025 at 07:37 PM

Ikena Oncology, Inc. (IKNA:NASDAQ) rocketted at $17.16, representing a gain of 1152.6%. The stock got featured on our News Catalysts scanner on Fri, Jul 25, 2025 at 12:35 PM in the 'MERGER' category. From Wed, Jul 16, 2025, the stock recorded 40.00% Up Days and 54.55% Green Days

About Ikena Oncology, Inc. (IKNA:NASDAQ)

Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.

Top 10 Gainers:

Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
Hempacco Co., Inc. (HPCO:NASDAQ), 800%
Replimune Group, Inc. (REPL:NASDAQ), 101.33%
XBP Europe Holdings, Inc. (XBP:NASDAQ), 81.09%
SRM Entertainment, Inc. (SRM:NASDAQ), 53.27%
Safe and Green Development Corporation (SGD:NASDAQ), 53.17%
Super X AI Technology Ltd Ord (SUPX:NASDAQ), 43.98%
707 Cayman Holdings Limited (JEM:NASDAQ), 41.31%
ATA Creativity Global (AACG:NASDAQ), 33.36%
Top Wealth Group Holding Limited (TWG:NASDAQ), 29.31%